CA2319777C - Dideoxy dye terminators - Google Patents

Dideoxy dye terminators Download PDF

Info

Publication number
CA2319777C
CA2319777C CA002319777A CA2319777A CA2319777C CA 2319777 C CA2319777 C CA 2319777C CA 002319777 A CA002319777 A CA 002319777A CA 2319777 A CA2319777 A CA 2319777A CA 2319777 C CA2319777 C CA 2319777C
Authority
CA
Canada
Prior art keywords
dna
compound
polymerase
dye
ident
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002319777A
Other languages
French (fr)
Other versions
CA2319777A1 (en
Inventor
Shiv Kumar
Satyam Nampalli
Bernard F. Mcardle
Carl W. Fuller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Life Sciences Solutions USA LLC
Original Assignee
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Bio Sciences Corp filed Critical GE Healthcare Bio Sciences Corp
Publication of CA2319777A1 publication Critical patent/CA2319777A1/en
Application granted granted Critical
Publication of CA2319777C publication Critical patent/CA2319777C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Abstract

A kit for DNA sequencing comprising a first, second, third and fourth dye terminator molecules, each of the dye terminator molecules comprising a dye molecule, a linker of at least 10 atoms in length and eithe r ddATP, ddCTP, ddGTP or ddTTP as a mono or tri-phosphate and a thermostable DNA polymerase.

Description

FIELD OF THE INSTEH'TION
This invention relates to dye terminator nucleic acid sequencing and reagents for such sequencing.
BACKGROUND OF THE INVIs'NTION
The following is a discussion of the relevant art, none of which is admitted to be prior art to the appended claims.
Sequence reaction products must be labeled. This can be done using labeled primers, labeled nucleotides (usually radioactive dNTPs) or labeled ddNTP
terminators. The use of labeled terminators has the advantage of leaving false-stops undetectable.
DNA sequence bands do not necessarily have uniform intensities. It is useful to express band intensity variability numerically. This can be done by reporting the ratio of maximum to minimum intensity of nearby bands (within a window of perhaps 40 bases) in a DNA
sequence or, with normalization and correction for systematic "drift" in intensity by reporting the root mean square of band intensities (typically peak heights)(Fuller, C.W., Comments 16(3):1-8, 1989). It is advantageous to have uniformity of band intensity as sequence accuracy and read-length is improved with,bands.
of more uniform intensity.
For accurate reading, the mobility of any given sequencing reaction product must migrate through the electrophoresis gel with a speed proportional only to its length. Products which migrate faster or slower than normal for a given length will result in sequence ambiguities or errors known as "compressions".
Anomalous migration speed can be caused by secondary structure of the DNA and is apparently the cause of most "compression" artifacts seen in radioactive-label (and other) sequencing experiments at GC-rich regions. These can often be resolved by the use of analogs of dGTP such as 7-deaza-dGTP or dITP.
Another compression-like artifact is observed when some dye-labeled ddNTPs are used for sequencing. Several examples of this can be seen in Lee, L.G., Connell, C.R., Woo, S.L., Cheng, R.D., McArdle, B.F., Fuller, C.W., Halloran, N.C., and Wilson. R.K., Nucleic.Acids Res., 20:2471-2483, 1992 (see figures 4g, 4h and 6h using ddCTP labeled with tetramethylbodipy and TMR.or ddGTP labeled with bifluor). These-compression-like artifacts are produced, even in sequences which are compression-free when sequenced radioactively or with dye-labeled primers. These artifacts can sometimes be eliminated by substituting dITP for dGTP or alpha-thio dNTPs for normal dNTPs (Lee, L.G. et al., Nucleic Acids Res., 20: 2471-2483, 1992; U.S. Patent No. 5,187,085).
Similar artifacts seen with the fluorescein dye-labeled ddNTPs sold by Applied Biosystems for dye-terminator sequencing with T7 DNA polymerase are resolved by substituting alpha-thio dNTPs for normal dNTPs (Lee, L.G. et al., Nucleic Acids Res., 20s 2471-2483, 1992;
U.S. Patent No. 5,187,085_).

Prober, J.M., Trainor, G.L., Dam, R.J., Hobbs, F.W., Robertson, C.W., Zagursky, R.J., Cocuzza, A.J., Jensen, M.A. and Baumeister, K., Science 238:336-41 (1987) performed sequencing using terminators labeled with substituted succinyl-fluoresceins with linkers of atoms in length, together with dATP, dCTP, dTTP, 7-deaza-dGTP and AMV reverse transcriptase, and a 10 fluorescence-detecting instrument. From Fig. 6 of this paper is clear that overall-band intensities varied by more than 10-fold, far more than the best available current methods with dye primers or radioactive labels.
Dideoxy NTP terminators that have the same basic structure as the Prober et al. (1987) terminators, but have four rhodamine dyes used in place of the succinyl fluoresceins and linkers of 5 atoms in length, have been used for sequencing with Taq polymerase. In order to use these terminators, dITP is used in place of dGTP or 7-deaza-dGTP to eliminate severe "compression"
artifacts. This method has been practiced using cloned Taq DNA polymerase(Bergot, WO 9105060; Parker, L.T;, Deng, Q, Zakeri, H., Carlson, C. Nickerson, D.A., Kwok, P.Y., Biotechn3ques 19(1):116-121, 1995) and with a mutant of Taq polymerase (D49G, AmpliTaq CS) lacking 51-31 exonuclease activity. However, band intensities vary by as much as 20-fold, limiting the accuracy.and read-length possible with the method (Parker, L.T., Zakeri, H., Deng, Q., Spurgeon, S.., Kwok, P.Y., Nickerson, D.A., Biotechn3.ques 21(4) :694-699, 1996).
Lee, L.G., Connell, C.R., Woo, S.L., Cheng, R.D., McArdle, B.F.., Fuller, C.W., Hallorand, N.D. and Wilson, R.K., Nuc2eic Acids Res., 20:2471,1992)describe sequencing with a set of ddNTP terminators and T7 DNA
polymerase. All have fluorescein-type dyes attached to the ddNTPs in essentially the same manner as the rhodamine terminators used for Taq sequencing. These are used with modified T7 DNA polymerase (Sequenase' version 2.0) and alpha-thio dNTPs. The thio dNTPs are used to resolve the "compression" artifacts like dITP is used for the Taq dye-terminator methods. The results with this system are such that bands vary in intensity about 10-fold.
Wayne Barnes has published a protocol for dye-terminator sequencing with FY modified polymerases and Mn'= (Scientech Corp. St. Louis, MO). Bands are more uniform with this method varying about 4.5-fold at most.
Fluorescein-12 ddNTPs that have a linker length-of . , .
12 atoms and Biotin-11 ddNTPs that have a linker length of 11 atoms are available (Dupont NEN, Wilmington, DE).
These labeled ddNTPs are described as useful in sequencing reactions.
ABI PRISM disclose dichlororhodamine dyes linked to terminators by propargyl/ethylene oxide/amino ("EO") linkers eight atoms-in length for sequencing (Rosenblum, B.B., Lee, L.G., Spurgeon, S.L., Khan, S.H., Menchen, S.M., Heiner, C.R., and Chen, S.M., Nucleic Acids Res.
25(22):4500-4504, 1997).

. 5 Cyanine dyes have been utilized in dye terminators for sequencing (Lee et al., Nucleic Acids Res., 20 (10) :2471, 1992).

j$UNIIKARY OF THE INt7ENTION
The present invention provides novel dideoxy dye-labeled terminators which are useful in a number of biological processes, including providing uniform band intensities and the resolution of dye-induced compression artifacts in DNA sequencing. The dideoxy dye-labeled terminators of the present invention are particularly well suited for use with DNA polymerases that are thermostable or which contain an altered dNMP
binding site (Tabor et al., U.S. Patent No. 5,614,365).
Use of the terminators of the present invention for sequencing does not require the use of nucleotide analogs such as dITP or alpha-thio nucleotides to eliminate dye-induced compression artifacts.. Applicant has surprisingly found that there is a strong correlation between the length of the link between the dye molecule and the nucleotide and band uniformity, but little correlation between the type of dye (or other parameters) and band uniformity. Dye terminators with linkers of 10 or more atoms (extended linkers) up to 25 atoms (10, 11, 12.....25) when used in sequencing reactions produce bands in.sequencing gels of significantly.improved uniformity compared with dye terminators with linkers less than 10 atoms.
The dye termininators of the present invention with extended linkers typically are provided in groups of four (ATGC) with or without a thermostable DNA
polymerase and are especially useful in a method of sequence analysis.

In a first aspect, the invention features a kit for DNA sequencing having a first, second, third and fourth dye terminator molecule, each of the dye terminator molecules has a dye molecule, a linker of at least 10 atoms in length and either ddATP, ddCTP, ddGTP or ddTTP
as a mono or tri-phosphate and a thermostable DNA
polymerase.
By "dye molecule" is meant any molecule that has a detectable emission spectrum, including but not limited to fluorescein, rhodamine, texas red, eosin, lissamine, coumarin, cyanine, and derivatives of these molecules.
Dyes also include energy transfer dyes each comprising a donor and an acceptor dye.
By "linker" is meant a chain of at least 10 atoms comprising carbon, nitrogen, and oxygen which links the dye molecule with the dideoxynucleotide. The chain may also contain substituted carbon or sulfur. Linkage typically occurs at the aromatic base moiety of the nucleotide. The first two atoms of the linker attached to the base are typically.joined in a triple bond..
By "substituted carbon " is meant that one or more hydrogens are replaced with a substitute group such as, but not limited to, hydroxyl, cyano, alkoxy, oxygen, sulfur, nitroxy, halogen, -NICH,) z, amino; _ and -SH.
By "thermostable DNA polymerase" is meant a DNA
polymerase has a half-life of greater than 5 minutes at 90 C. Such polymerases include, but are not limited to, DNA polymerases encoded by Thermus aquaticus, Thermus thermophilus, Thermus flavus, Thermococcus littoral3 s, Pyrococcus furiosus, Thermotoga maritima, and Thermotoga neapolitana.
In a preferred embodiment the thermostable DNA
polymerase has an altered dNMP binding site so as to improve the incorporation of dideoxynucleotides relative to the natural polymerase. A DNA polymerase with an altered dNMP binding site does not discriminate significantly between dideoxynucleotides and deoxynucleotides. The chance of incorporating a dideoxynucleotide is approximately the same as that of a deoxynucleotide or at least 1/10 the efficiency of a deoxynucleotide.
In a second aspect the invention features a compound of formula (I) A
I
B
1.
C
A.is a cyanine dye of the structure H H lY
~~C~C~
m RS~X N Re Rl R2 wherein the curved lines represent carbon atoms necessary for the formulation of cyanine dyes; X and Y
are selected from the group consisting of 0, 8, and*

CH3-C-CH3; m is an integer selected from 1, 2, 3, and 4; R1, R2, R3, R4, R5, R6, and R7 are independently selected from the group consisting of H, OH, C02H, . sulfonic acid or eulfonate groups, esters, amides, ethers, alkyl or aryl groups, and B and one R1, R2, R3, R4, RS, R5 or R7 is B.
B is a linker of at least 10 atoms in length wherein the atoms are selected from carbon, nitrogen, oxygen, substituted carbon and sulfur and the linker is attached at one end to A and at the other end to C.
C is a dideoxynucleotide selected from ~
o Nhlt o NIi2 ~ 7 HN N HN N
lw~N N ~N N p N

R-0 a. p 0 R~

aC]d and wherein the linker is covalently bonded to the dideoxynucleotide at position 7 for the purines (ddG, ddA) and at position 5 for the pyrimidines (ddT, ddC), and wherein r is a mono or tri-phosphate.
The term "aulfonic'acid.or aulfonate groups" refer to S03H groups or salts thereof.
The term 'Iester" refers to a chemical- moiety with formula -(R) n-COOR' , where R and R' are independently selected from the group consisting of saturated or unsaturated alkyl and five-membered or six-membered aryl or heteroaryl moieties and where n is 0 or 1.
The term "amide" refers to a chemical substituent of formula -NHCOR, where R is selected from the group consisting of hydrogen, alkyl, hydroxyl, and five-membered or six-membered aryl or heteroaryl ring moieties, where the ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl,.halogen, trihalomethyl, carboxylate, nitro, or ester.
The term "ether" refers to a chemical moiety with formula R-O-R' where R and R' are independently selected from the group consisting of saturated or unsaturated alkyl and five-membered or six-membered aryl or heteroaryl moieties and where n is 0 or 1.
The term "alkyl" refers to a straight-chain or.
branched aliphatic hydrocarbon. The alkyl group is preferably 1 to 10 carbons, more preferably a lower alkyl of from 1 to 7 carbons, and most preferably 1 to 4 carbons. Typical alkyl groups include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tertiary butyl, pentyl, hexyl and the like. The alkyl group may be substituted and some typical alkyl substituents include hydroxyl, cyano, alkoxy, oxygen, sulfur, nitroxy, halogen, -N(CH3)21 amino, and -SH.
The term "aryl" refers to an aromatic group which has at least one ring having a conjugated_pi electron system and includes.both carbocyclic aryl (e.g. phenyl) and heterocyclic aryl groups (e.g. pyridine). The term "carbocyclic" refers to a compound which contains one.or more covalently closed ring structures, and that the atoms forming the backbone of the ring are all carbon atoms. The term thus distinguishes carbocyclic from heterocyclic rings in which the ring backbone contains 5 at least one atom which is different from carbon. The term "heteroarly" refers to an aryl group which contains at least one heterocyclic ring.
In a preferred embodiment the linker is selected from 10, -C~C-CS,-rrH-co- (Ca,),-rni-co-, -C~C-Cti,-rrs-CO- (cS,),-NS-so,-, -C*C-CS2-NS-CO- (CIi2) io-21H-CO-, -CzC-CH2-NS-CO- (CAa) s- A
-CeC-CH2-NH-CO- (CFI1) s-NH-CO- (CHs) s-, and 1S -CKC-CB=-NH-CO- ((M3) s=2dH-Co- (CHr) SC-NH-CO=
Sn preferred embodiments the dideoxy dye terminators are; a compound of the formula (IY):
VWA

v ~ oo- a ;a compound of the formula (III):

so,=
=gs so,' N II' P' ~

a o=

; a compound of the formula (IV):

NH
HMN
~ ft o~

o- o- o-; compound of the formula (V) :

so,.

sa N=

O
N

NF4 .
a o a The.Cy-5.5 ddGTP and ddCTP compounds have a linker of 10 atoms in length. The Cy-5.5 ddCTP and ddTTP
compounds have a linker of 17 atoms in length.

In a third aspect the.invention features a deoxyribonucl.eic-acid sequence containing the compound of formula I, II, III ;IV or V.
in a preferred embodiment the invention features a kit for DNA sequencing comprising compounds of formuTa II, III, IV, and V, and instructions for using said compounds for DNA sequencing.

In a further preferred embodiments the kit.further has a thermostable DNA polymerase; the thermostable DNA
polymerase has an altered dNMP binding site so as to improve the incorporation of dideoxynucleotides relative to the natural polymerase.

Applicant has surprisingly found that the one parameter that most strongly correlates with band uniformity is the length of the linker between the dye and the ddNTP. Applicant has found that by extending' the linker length between the dye and the nucleotide 'for any dye:ddNTP combination to at least 10 atoms, that band uniformity is substantially improved and there are no dye-induced compression artifacts.
Thus, in a fourth aspect, the invention features a method for determining the nucleotide base sequence of a DNA molecule consisting of the steps of incubating a DNA
molecule annealed with a primer molecule able.to hybridize to the DNA. molecule in a vessel containing a thermostable DNA polymerase, a dye terminator with a linker of at least 10 atoms between the dye and the nucleotide and separating DNA products of the incubating reaction according to size whereby at least a part.of the nucleotide base sequence of the DNA molecule can be determined.
In preferred embodiments, the-dye terminator is a compound of formula I, II, III, IV or V; the thermostable DNA polymerase has an altered dNMP binding site.

Other features and advantages of the invention will be apparent from the following description of the preferred embodiments thereof, and from the claims.

BRIEF DESCRIPTION OF THE FIGURES

5 Fig. 1 presents DNA sequence data generated using M13mp18 containing a 115 bp SauAI fragment from lambda inserted at the BamHI site and Cy5.5 ddGTP, ddATP, ddTTP, and ddCTP dye terminators.

Fig. 2 is a graph of band intensity variability 10 (rms) vs linker length (atoms).

DESCRIPTION OF THE PREFERRED EMBODIMENTS

The following Examples are provided for further illustrating various aspects and embodiments of the present invention and are in no way intended to be limiting of the 15 scope.

Example 1: Synthesis of dideoxy dye terminators Cy 5.5 dideoxynucleotide triphosphates Dye terminators labeled with Cy5.5 were prepared from propargylaminodideoxynucleotides (Prober J.M., Trainor, G.L., Dam, R.J., Hobbs, F.W., Robertson C.W., Zagursky, R.J., Cocuzza, A.J., Jensen, M.A. and Baumeister, K., Science 238:336-41 (1987); U.S. Patent Nos. 5,242,796, 5,306,618, and 5,332,666) and "CyDye Fluorolink Cy5.5 mono reactive dye" product PA25501 (Amersham Life Science) to produce compounds II, III, IV, and V. In the case of ddG and ddA, the propargylaminonucleotide was directly reacted with the N-hydroxysuccinimidyl ester of the Cy5.5 dye. In the case of ddC and ddT, a longer linker was constructed by reacting the propargylaminonucleotide with the N-hydroxysuccinimidyl ester of N-trifluoroacetyl-6-aminocaproic acid followed by hydrolysis in aqueous ammonia of the trifluoroacetyl group. The resulting compound was then reacted with the N-hydroxysuccinimidyl ester of the Cy5.5 dye to give the 17-atom linker between the Cy 5.5 dye and the pyrimidine base.
In addition to Cy 5.5 dyes, those who practice the art would know how to identify and utilize other dyes, including other cyanine dyes, with the appropriate.
optical properties. Also, the construction and attachment of various linkers is well known in the art.
Suitable reagents for linker construction include one or more compounds consisting of activated forms of amino-protected alkyl or aryl amino acids such as compounds of the formula R-NH- (CHz) n-COzR' or R-NH- (CHz),X(CH,) m-COzR' , where R is an acid- or base-labile protecting group,.R' is a reactive ester or anhydride group, X is aryl, 0; S, or NH, and where n and m are 0-12. Other linkers constructed by N- or 0- or S- alkylation are also suitable. The exact linker length, of at least 10 atoms, for a specific dye and dideoxynucleotide combination can be determined empirically by monitoring band uniformity in DNA sequencing as described (see Example 3).

Example 2: Dye terminator cycle sequencing DNA cycle sequencing was carried out using Thermo SequenaseTM DNA polymerase (Amersham, Cleveland, OH) and Cy5.5 dideoxy dye terminators using the following cycle sequencing protocol:

1. A master mix was prepared consisting of the following:
Template DNA 5.Opl lOX Reaction buffer (see below) 3.5ul Primer, 2pM 1.0}.il Polymerase (see below) 2}z H2O 15 . 5pl Total volume 27.0p1 lOX Reaction Buffer:

150 mM Tris HCL pH 9.5 35mM MgC12 Polymerase: Thermo SequenaseTM DNA polymerase, 10U/}il, 0.0017U/pl, Thermoplasma acidophilum inorganic pyrophosphatase: 20mM Tris-HCl, pH 8.5, 1mM DTT, 0.1mM
EDTA, 0.5% Tween-20TM, 0.5% Nonidet P-40TM and 50% glycerol.

2. Four microcentrifuge tubes were labeled and 2/.cl of Cy5.5 labeled ddG, ddA, ddT, ddC solution was added to each tube.

25:1 ddG Mix, 300 luM each of dGTP, dATP, dTTP & dCTP, 12/.cM Cy5.5 ddGTP

25:1 ddA Mix, 300 /.cM each of dGTP, dATP, dTTP & dCTP, 12j.tM Cy5.5 ddATP

25:1 ddT Mix, 300 gM each of dGTP, dATP, dTTP & dCTP, 12/,tM Cy5..5 ddTTP

25:1 ddC Mix, 300 IcM each of dGTP, dATP, dTTP & dCTP, 12/sM Cy5.5 ddCTP

3. Six l of the master mix (from step 1) was aliquoted to each of the 4 tubes from step 2 above.
Cycling was carried out as follows: 95 C (30 sec), 45-55 C (30 sec) and 72 C (60 sec) for 35 cycles then incubate at 72 C 5-7 minutes.

4. One iul of 8M ammonium acetate was added to each tube. Theii 27 lcl (approximately 3 times the reaction volume) of chilled 100% ethanol was added. Then mixture was mixed and placed on ice for 20 minutes to precipitate the DNA.

5. The mixture was centrifuged in a microcentrifuge (-12,000rpm) for 20-30 minutes at either room temperature or 4 C. The supernatant was removed and then 200 i.cl of 70* ethanol was added to wash the DNA
pellet.
6. The mixture was again centrifuged for 5 minutes, the supernatant removed and the pellet dried (in a vacuum centrifuge) for 2-3 minutes.
7. Each pellet was resuspended in 6 l of formamide loading dye (Amersham, Cleveland, OH), vortexed vigorously (10-20 sec) to ensure that all DNA was dissolved. The mixture was briefly centrifuged to collect the sample at the bottom of the tube.
8. Samples were heated to 70 C for 2-3 minutes to denature the DNA, then placed on ice.
9. Then 1.5-2 jul of the volume was loaded onto a lane of the sequencing gel, and the gel run on the MICRO Gene Blaster instrument (VGI).

For this sequence, the template DNA was M13mp18 containing a 115 bp Sau3AI fragment from bacteriophage lambda inserted at the BamHI site (product number US
70171 Amersham). The primer is the -40 Forward 23-mer universal primer (5'-GTTTTCCCAGTCACGACGTTGTA-3')(SEQ.
ID. NO. 1). Results are shown in Figure 1.

Example 3: Correlation of linker length and band intensity variability Sequencing reactions were carried out as described in example 2 with various dye molecules linked to dideoxynucleotides with linkers of various lengths (see Table 1). The labeled DNA products were then separated on denaturing polyacrylamide gels and the labeled products were detected by fluorescence. The intensity of the bands is taken as the height of the peaks in a graph of fluorescence (in arbitrary units) against time.
5 Typically, systematic variations in peak heights can be seen in graphs of peak heights plotted sequentially.
These systematic variations in the peak heights can be modeled by least-square fitting to a second-order polynominal function. Dividing the peak height for each 10 band by the value of the curve-fit polynomial function yields a normalized band intensity for each peak.
Variation in these band intensities can be expressed as the square root of the variance (nEx2-(Ex)2 /n2) of.the normalized peak heights, which can typically have values 15 between 0 and 1 with more variability represented by higher numbers (Fuller, C.W., Comments 16(3):1-8, 1989).
This value is numerically equal to root-mean-square (RMS) value when 1.0 is subtracted from the normalized peak heights. These values are reported in Table 1 and 20 graphed in Fig. 2. Variability of band intensities is significantly reduced when linkers of 10 or more atoms in length were used, resulting in sequence data that was easier to interpret accurately.

Table 1 Base Dye= Linker Sand Uniformity Lengthb ( tmB ) 1 T Coumarin 5 0.32 2 a Lissamine 5a 0.77 3 C3 R110 5 0.34 4 A R6Ci 5e 0.32 d R6(3 5e 0.57 6 C ROX 5e 0.36 5 7 T TlU2 5 0.47 8 A TxR 5 0.61 9 C Rosin 60 0.40 (3 Cy3 l0i 0.24 11 A Cy5 l0i 0.15 10 12 C3 Cy5 l0s 0.21 13 A Cy5.5 101 0.21 14 a Cy5.5 l0i 0.20 A F1 12= 0.16 16 C Fl 12= 0.20 15 17 C3 Fl 129 0.17 18 T F1 12f 0.18 19 A R6G 12= 0.13 T R6(i 12= 0.25 21 A ROX 12f 0.21 20 22 T ROX 12E 0.16 23 C TNIIt 12= 0.26 24 C3 TNIIt 129 0.29 T TMR 12= 0.37 26 A TxR 169 0.32 25 27 C TxR 169 0.24 28 O TXR 169 0.22 29 U Tidt 169 0.24 A Cy3-CyS 171 0.11 31 C Cy3-Cy5 171 0.16 30 32 G Cy3-Cy5 17J 0.22 33 T Cy3-Cy5 17j 0.11 34 C Cy5 17J 0.14 35 T Cy5 171 0.10 36 C Cy5.5 17i 0.20 37 T Cy5.5 17J 0.18 38 A Fl 17 0.16 39 C Fl 17h 0.24 40 G F1 17 0.18 41 T F1 17k 0.25 42 T F1 24k 0.24 ' Abbreviations for dyes: Fl, Carboxyfluorescein; R110, Rhodamine 110; R6G, Rhodamine 6G; ROX, Rhodamine X; Tt+St, tetramethylrhodamine;
TXR, Texas Red (Molecular Probes). The dyes Cy3, Cy3.5, Cy5 and Cy5.5 were from Amersham Life Science, Cleveland, OH.

b Linker length is the number of atoms between the ring structure of the nucleoside base (A, C, G or T) and the ring structure of.the dye.

Linker structures -CsC-CH=-NB-CO-2 0 d -CQC-CH1-NH-802-= -CUC-CH3-IdFI-CS-NH--CEC-CHl-Nfi-CO- (CH=) 5-1JH-CO-4 -C~C-C81-1d8-CO- (C81) f-NH-BOl--C=C-C$3-NS-CO- (CHi)10-bix-CO-1 -CeC-CBz-NB-CO- (CS=) s--CEC-Cii2-'NS-CO- (CFh) a-1JIi-CO- (CSO 5-k -C.'UC-CQi3-NH-CG- (CS3) f-INH-Co- (CH2)10-NB-CO-SEQUENCE LISTING
<110> Kumar, Shiv Nampalli, Stayam McArdle, Bernard F.
Fuller, Carl W.
<120> DIDEOXY DYE TERMINATORS
<130> 225/219 WO

<140> PCT/US99/02104 <141> 1999-02-02 <150> 09/018,695 <151> 1998-02-04 <160> 2 <170> FastSEQ for Windows Version 4.0 <210> 1 <211> 23 <212> DNA
<213> Bacterial Plasmid <400> 1 gttttcccag tcacgacgtt gta 23 <210> 2 <211> 390 <212> DNA
<213> Bacterial Plasmid <400> 2 acggccagtg ccaagcttgc atgcctgcag gtcgactcta gaggatcccc gggtaccgag 60 ctcgaattcg taatcatggt catagctgtt tcctgtgtga aattgttatc cgctcacaat 120 tccacacaac atacgagccg gaagcataaa gtgtaaagcc tggggtgcct aatgagtgag 180 ctaactcaca ttaattgcgt tgcgctcact gcccgctttc cagtcgggaa acctgtcgtg 240 ccagctgcat taatgaatcg gccaacgctc ggggagaggc ggtttgcgta ttgggcgcca 300 gggtggtttt tcttttcacc agtgagacgg gcaacagctg attgcccttc accgcctggc 360 cctgagagag ttgcagcaag cggtccacgc 390

Claims (13)

CLAIMS:
1. A compound of formula (I):
wherein A is a cyanine dye of the structure wherein the curved lines represent carbon atoms necessary for the formulation of cyanine dyes, X and Y are selected from O, S, and CH3-C-CH3, m is an integer selected from 1, 2, 3, and 4, R1, R2, R3, R4, R5, R6 and R7 are independently selected from H, OH, CO2H, sulfonic acid or sulfonate groups, esters, amides, ethers, alkyl or aryl groups and B, and one R1, R2, R3, R4, R5, R6 or R7 is B;

B is a linker attached at one end to A and at the other end to C, and selected from -C.ident.C-CH2-NH-CO-(CH2) 5-NH-CO-, -C.ident.C-CH2-NH-CO-(CH2) 9-NH-SO2-, -C.ident.C-CH2-NH-CO- (CH2)10 -NH-CO-, -C.ident.C-CH2-NH-CO-(CH2)5-, -C.ident.C-CH2-NH-CO-(CH2) 5-NH-CO-(CH2) 5-, and -C.ident.C-CH2-NH-CO-(CH2)5-NH-CO- (CH2)10-NH-CO-; and C is a dideoxynucleotide selected from wherein said linker is covalently bonded to said dideoxynucleotide at position 7 for ddA and ddG and at position 5 for ddC and ddT and wherein R is a mono or triphosphate.
2. A compound of the formula (II):
3. A compound of the formula (III):

4. A compound of the formula (IV):

5. A compound of the formula (V):

6. A deoxyribonucleic acid sequence containing the compound of claim 1.
7. A deoxyribonucleic acid sequence containing the compound of any one of claims 2 to 5.
8. A kit for DNA sequencing comprising compounds of any one of claims 2 to 5, and instructions for using said compounds for DNA sequencing.
9. The kit of claim 8 further comprising a thermostable DNA polymerase.
10. The kit of claim 9, wherein said polymerase is a thermostable DNA polymerase that has an altered dNMP binding site so as to improve the incorporation of dideoxynucleotides relative to the natural polymerase.
11. Method for determining the nucleotide base sequence of a DNA molecule comprising the steps of:
incubating a DNA molecule annealed with a primer molecule able to hybridize to said DNA molecule in a vessel containing a thermostable DNA polymerase, a compound of claim 1, and separating DNA products of the incubating reaction according to size whereby at least a part of the nucleotide base sequence of said DNA molecule can be determined.
12. Method for determining the nucleotide base sequence of DNA molecule comprising the steps of:
incubating a DNA molecule annealed with a primer molecule able to hybridize to said DNA molecule in a vessel containing a thermostable DNA, a compound of any one of claims 2 to 5, and separating DNA products of the incubating reaction according to size whereby at least a part of the nucleotide base sequence of said DNA molecule can be determined.
13. The method of claim 11 or 12, wherein said polymerase is a thermostable DNA polymerase that has an altered dNMP binding site so as to improve the incorporation of dideoxynucleotides relative to the natural polymerase.
CA002319777A 1998-02-04 1999-02-02 Dideoxy dye terminators Expired - Fee Related CA2319777C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1869598A 1998-02-04 1998-02-04
US09/018,695 1998-02-04
PCT/US1999/002104 WO1999040223A1 (en) 1998-02-04 1999-02-02 Dideoxy dye terminators

Publications (2)

Publication Number Publication Date
CA2319777A1 CA2319777A1 (en) 1999-08-12
CA2319777C true CA2319777C (en) 2008-01-08

Family

ID=21789323

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002319777A Expired - Fee Related CA2319777C (en) 1998-02-04 1999-02-02 Dideoxy dye terminators

Country Status (8)

Country Link
US (1) US6949635B1 (en)
EP (1) EP1060264B1 (en)
JP (1) JP4306960B2 (en)
AT (1) ATE299190T1 (en)
AU (1) AU2571799A (en)
CA (1) CA2319777C (en)
DE (1) DE69926057T2 (en)
WO (1) WO1999040223A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4306960B2 (en) * 1998-02-04 2009-08-05 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション Dideoxy dye terminator
US7875440B2 (en) 1998-05-01 2011-01-25 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US6780591B2 (en) 1998-05-01 2004-08-24 Arizona Board Of Regents Method of determining the nucleotide sequence of oligonucleotides and DNA molecules
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US6358684B1 (en) * 1999-08-27 2002-03-19 Pe Corporation UV excitable fluorescent energy transfer dyes
CA2382063A1 (en) * 1999-09-17 2001-03-22 Shiv Kumar Charge-modified nucleic acid terminators
US6811979B2 (en) 2000-10-11 2004-11-02 Applera Corporation Fluorescent nucleobase conjugates having anionic linkers
JP4676654B2 (en) * 2001-07-19 2011-04-27 富士フイルム株式会社 Fluorescent nucleotide and labeling method using the same
US20050119587A1 (en) * 2003-07-01 2005-06-02 University Of Michigan Method and apparatus for evaluating connective tissue conditions
US8417322B2 (en) * 2003-07-01 2013-04-09 Regents Of The University Of Michigan Method and apparatus for diagnosing bone tissue conditions
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
WO2005080605A2 (en) 2004-02-19 2005-09-01 Helicos Biosciences Corporation Methods and kits for analyzing polynucleotide sequences
US8227621B2 (en) * 2005-06-30 2012-07-24 Li-Cor, Inc. Cyanine dyes and methods of use
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US7729749B2 (en) * 2005-09-01 2010-06-01 The Regents Of The University Of Michigan Method and apparatus for evaluating connective tissue conditions
JP2009508571A (en) * 2005-09-16 2009-03-05 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン Method and system for measuring composition directly under surface of specimen
US20090246762A1 (en) * 2008-03-31 2009-10-01 Applera Corporation, Applied Biosystems Group Nucleic acid terminators incorporating a cationic moiety and methods for their use
JP2012524153A (en) * 2009-04-17 2012-10-11 ライコア インコーポレイテッド Fluorescence imaging using substituted cyanine dyes
EP2630196B1 (en) 2010-10-20 2017-09-06 Li-Cor, Inc. Cyanine dyes and their conjugates
US9085698B2 (en) 2011-09-23 2015-07-21 Illumina Cambridge Limited Dyes for labelling molecular ligands
US8809551B1 (en) 2013-03-08 2014-08-19 Illumina Cambridge Limited Polymethine compounds and their use as fluorescent labels
GB201408077D0 (en) 2014-05-07 2014-06-18 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
GB201508858D0 (en) 2015-05-22 2015-07-01 Illumina Cambridge Ltd Polymethine compounds with long stokes shifts and their use as fluorescent labels
GB201516987D0 (en) 2015-09-25 2015-11-11 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340806C (en) 1986-07-02 1999-11-02 James Merrill Prober Method, system and reagents for dna sequencing
US5242796A (en) 1986-07-02 1993-09-07 E. I. Du Pont De Nemours And Company Method, system and reagents for DNA sequencing
US5795762A (en) * 1986-08-22 1998-08-18 Roche Molecular Systems, Inc. 5' to 3' exonuclease mutations of thermostable DNA polymerases
US5366860A (en) 1989-09-29 1994-11-22 Applied Biosystems, Inc. Spectrally resolvable rhodamine dyes for nucleic acid sequence determination
US5187085A (en) 1990-09-28 1993-02-16 Applied Biosystems, Inc. Nucleic acid sequence analysis with nucleoside-5'-o-(1-thiotriphosphates)
US5614365A (en) * 1994-10-17 1997-03-25 President & Fellow Of Harvard College DNA polymerase having modified nucleotide binding site for DNA sequencing
US5795782A (en) 1995-03-17 1998-08-18 President & Fellows Of Harvard College Characterization of individual polymer molecules based on monomer-interface interactions
US5986086A (en) * 1997-06-20 1999-11-16 Amersham Pharmacia Biotech Inc. Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides
JP4306960B2 (en) * 1998-02-04 2009-08-05 ジーイー・ヘルスケア・バイオサイエンス・コーポレイション Dideoxy dye terminator

Also Published As

Publication number Publication date
ATE299190T1 (en) 2005-07-15
US6949635B1 (en) 2005-09-27
EP1060264A1 (en) 2000-12-20
JP2002505853A (en) 2002-02-26
WO1999040223A1 (en) 1999-08-12
DE69926057T2 (en) 2006-04-20
EP1060264A4 (en) 2001-07-04
JP4306960B2 (en) 2009-08-05
DE69926057D1 (en) 2005-08-11
AU2571799A (en) 1999-08-23
EP1060264B1 (en) 2005-07-06
CA2319777A1 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
CA2319777C (en) Dideoxy dye terminators
JP5280879B2 (en) Substituted propargyl ethoxyamide nucleoside
US6248568B1 (en) Propargylethoxyamino nucleotide primer extensions
JP4318296B2 (en) Labeled nucleoside polyphosphate
EP1198594B1 (en) Polymerase extension at 3&#39; terminus of pna-dna chimera
AU764099B2 (en) Polynucleotide sequencing method
JP5085837B2 (en) Terminal phosphate-labeled nucleotide and method of use
JP4896707B2 (en) Solid phase sequencing
AU2015298469A1 (en) Modified nucleotide linkers
CA2275139A1 (en) Sets of labeled energy transfer fluorescent primers and their use in multi component analysis
JP2007524358A (en) Terminal phosphate-labeled nucleotide and method of use
AU2016266981A1 (en) Polymethine compounds with long stokes shifts and their use as fluorescent labels
WO2014013954A1 (en) Nucleic acid probe, method for designing nucleic acid probe, and method for detecting target sequence
JP2021515047A (en) New citric and reporter dye combinations
CA2321187A1 (en) Rna polymerase transcription promoters and method for determining base sequence
WO2022129930A1 (en) Alkylpyridinium coumarin dyes and uses in sequencing applications
JP2015104329A (en) Design method of nucleic acid primer or nucleic acid probe, and detection method of target sequence
McGall Nucleoside triphosphate analogs for nonradioactive labeling of nucleic acids

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170202